Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Watterson

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Viruses|October 17, 2020
Genetic, Morphological and Antigenic Relationships between Mesonivirus Isolates from Australian Mosquitoes and Evidence for Their Horizontal TransmissionNatalee D Newton, Agathe M G Colmant, Caitlin A O'Brien, et al.
Ebiomedicine|October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Science (New York, N.Y.)|January 8, 2021
A broadly protective antibody that targets the flavivirus NS1 proteinNaphak Modhiran, Hao Song, Lidong Liu, et al.
The Journal of Infectious Diseases|November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Nature Microbiology|March 20, 2019
Determinants of Zika virus host tropism uncovered by deep mutational scanningYin Xiang Setoh, Alberto A Amarilla, Nias Y G Peng, et al.
Science Translational Medicine|December 13, 2019
A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virusJody Hobson-Peters, Jessica J Harrison, Daniel Watterson, et al.
The Journal of General Virology|March 14, 2018
New genotypes of Liao ning virus (LNV) in Australia exhibit an insect-specific phenotypeNatalie A Prow, Marcus G Mah, Joshua M Deerain, et al.
Scientific Reports|February 9, 2021
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobodyGuillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.
Journal of Medicinal Chemistry|March 17, 2021
Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus FusionG Stuart Cockerill, Richard M Angell, Alexandre Bedernjak, et al.
Nature Aging|November 13, 2023
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathologyJulio Aguado, Alberto A Amarilla, Atefeh Taherian Fard, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Viruses|October 17, 2020
Genetic, Morphological and Antigenic Relationships between Mesonivirus Isolates from Australian Mosquitoes and Evidence for Their Horizontal TransmissionNatalee D Newton, Agathe M G Colmant, Caitlin A O'Brien, et al.
Ebiomedicine|October 21, 2023
Long-term safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2 in adults aged 18-55 years or ≥56 years: 12-month results from a randomised, double-blind, placebo-controlled, phase 1 trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Science (New York, N.Y.)|January 8, 2021
A broadly protective antibody that targets the flavivirus NS1 proteinNaphak Modhiran, Hao Song, Lidong Liu, et al.
The Journal of Infectious Diseases|November 24, 2025
Safety and immunogenicity of a SARS-CoV-2 spike, subunit vaccine stabilised in the prefusion conformation by second generation Molecular Clamp evaluated in adults aged 18-55 years: a randomised, double-blind, active comparator, Phase I trialKeith J Chappell, Francesca L Mordant, Alberto A Amarilla, et al.
Nature Microbiology|March 20, 2019
Determinants of Zika virus host tropism uncovered by deep mutational scanningYin Xiang Setoh, Alberto A Amarilla, Nias Y G Peng, et al.
Science Translational Medicine|December 13, 2019
A recombinant platform for flavivirus vaccines and diagnostics using chimeras of a new insect-specific virusJody Hobson-Peters, Jessica J Harrison, Daniel Watterson, et al.
The Journal of General Virology|March 14, 2018
New genotypes of Liao ning virus (LNV) in Australia exhibit an insect-specific phenotypeNatalie A Prow, Marcus G Mah, Joshua M Deerain, et al.
Scientific Reports|February 9, 2021
Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobodyGuillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, et al.
Journal of Medicinal Chemistry|March 17, 2021
Discovery of Sisunatovir (RV521), an Inhibitor of Respiratory Syncytial Virus FusionG Stuart Cockerill, Richard M Angell, Alexandre Bedernjak, et al.
Nature Aging|November 13, 2023
Senolytic therapy alleviates physiological human brain aging and COVID-19 neuropathologyJulio Aguado, Alberto A Amarilla, Atefeh Taherian Fard, et al.
Pageof 12